Global /China /Healthcare /Medical Devices /688016
chevron_leftBack
Shanghai MicroPort Endovascular MedTech Co., Ltd. logo

Shanghai MicroPort Endovascular MedTech Co., Ltd.

688016
SSE: 688016 Delayed
102.32CNY 3.3%
15.12 USD
As of 16 June 2026, Shanghai MicroPort Endovascular MedTech Co., Ltd. has a market cap of $1.77B USD, ranking #7646 globally and #1928 in China. It ranks #627 in the Healthcare sector, and #127 in the Medical Devices industry.
Global Rank
7646
Country Rank
1928
Sector Rank
627
Industry Rank
127
Key Stats
Market Cap
$1.77BUSD
11.97B CNY
Enterprise Value
$1.46BUSD
9.91B CNY
Revenue (TTM)
$199.46MUSD
1.35B CNY
EBITDA (TTM)
$95.76MUSD
648.06M CNY
Net Income (TTM)
$83.19MUSD
563.33M CNY
EBITDA Margin
48%
Profit Margin
42%
PE Ratio
21.3
Forward PE
19.0
PS Ratio
8.9
PB Ratio
2.9
EV/EBITDA
15.0
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Qing Zhu open_in_new
Employees
822
Founded
2012
Website
endovastec.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
3.3% 2.3% -2% 8.2% -2.8% 22%

News

Loading...

Markets

Exchange Ticker Price
Shanghai Stock Exchange
MIC: XSHG
PRIMARY
688016
上海微创心脉医疗科技股份有限公司 Class A
ISIN: CNE100003MJ5
Shares Out.:
120.841M1 Shares Float: 69.968M2
TV:
SA:
YF:
GF:
BA:
MS:
102.32 CNY
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Shanghai MicroPort Endovascular MedTech Co., Ltd.

Shanghai MicroPort Endovascular MedTech Co., Ltd. engages in the research and development, manufacturing, sale, and services of aortic, peripheral vascular, and tumor intervention devices in China and internationally. The company offers Fontus, a branched stent graft system in surgical operation; CRONUS, a stent graft system in surgical operation; Hector, a multi-branch thoracic stent graft system; Cratos and Castor, a branched aortic stent graft system; Talos, a thoracic stent graft system; and Hercules, a thoracic stent graft system with low profile delivery system. It also provides Minos, an abdominal aortic stent graft and delivery System; Aorfix, an endovascular device designed for treating abdominal aortic aneurysms; Altura, a device designed for the endovascular repair of abdominal aortic aneurysms; Aegis, a bifurcated aortic stent graft system; and L-REBOA, an aortic occlusion balloon catheter. In addition, the company offers Reewarm PTX, a drug coated balloon PTA catheter; ReeAmber, a PTA balloon dilatation catheter; Reewarm, a PTA balloon dilatation catheter; Ryflumen, a peripheral high-pressure balloon dilatation catheter; and CROWNUS, a peripheral stent system; HawkMaster, a detachable fibered embolization coils; HawkNest, a fibered embolization coils; Veryan BM3D, which is designed for the treatment of symptomatic de novo lesions in the native superficial femoral artery; Vflower, a venous stent system; SeaDragon, a PTA balloon dilatation catheter; Vewatch, a vena cava filter; Vepack, a snare retrieval kit; VeinPro, an endovenous radiofrequency closure system; Reflow-speX, a support catheter; and DEMANTOID, a peripheral vascular guide wire. Further, it provides Tipspear, a transjugular liver access set. Shanghai MicroPort Endovascular MedTech Co., Ltd. was incorporated in 2012 and is based in Shanghai, the People’s Republic of China.

Similar Companies

Industry: Medical Devices (China)
Name
Market Cap diff.
PE
$30.08B
203.66B CNY
2K%
26.0
$13.62B
92.23B CNY
670%
48.5
$5.61B
38.02B CNY
218%
23.4
$5.53B
37.43B CNY
213%
52.7
688617
$5.04B
34.14B CNY
185%
39.6
$4.56B
30.86B CNY
158%
13.7
Industry: Medical Devices (Global)
Name
Market Cap diff.
PE
$173.27B
10K%
25.8
$160.73B
9K%
56.7
$159.07B
9K%
25.6
DHR
$126.55B
7K%
34.7
SYK
$120.69B
7K%
38.3
MDT
$101.9B
6K%
22.2
chevron_leftBack